|
|
206958 |
pcDNA3.1_hMed25 |
Homo sapiens mediator complex subunit 25 (MED25), transcript variant 1, mRNA (Homo sapiens)
|
Ross |
Feb 09, 2024 |
|
|
193383 |
nTALE+CD_for TUB_8N_1397NC |
For multiplex C-to-T base editing to introduce amino acid mutations in the coding sequence of AtTUBs. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193382 |
nTALECD for_TUB4S351F_1397NC |
For specific C-to-T base editing to introduce an amino acid mutation in the coding sequence of AtTUB4. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193381 |
nTALECD for_MSH1 exon21_1397NC |
For specific C-to-T base editing to introduce an amino acid mutation in the coding sequence of AtMSH1. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193380 |
nTALECD for_MSH1 exon5_1397NC |
For specific C-to-T base editing to introduce an amino acid mutation in the coding sequence of AtMSH1. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193379 |
nTALECD for_PKT3 exon12_1397NC |
For specific C-to-T base editing to introduce an amino acid mutation in the coding sequence of AtPKT3. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193378 |
nTALECD for_PKT3 exon1_1397NC |
For specific C-to-T base editing to introduce a nonsense mutation in the coding sequence of AtPKT3. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193377 |
nTALECD for_CYO1 exon2_1397NC |
For specific C-to-T base editing to introduce a nonsense mutation in the coding sequence of AtCYO1. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193376 |
nTALECD for_CYO1 exon1_1397NC |
For specific C-to-T base editing to introduce a nonsense mutation in the coding sequence of AtCYO1. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193375 |
p4RV |
Repeat 4 RV (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193374 |
p3RV |
Repeat 3 RV (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193373 |
p2RV |
Repeat 2 RV (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
193371 |
E2_pENTR_R4-R3_HSPter-RPS5A-NLS |
|
Arimura |
Feb 09, 2024 |
|
|
193370 |
pDESTpK7WG2-RPS5Ap-NLS-OleGFP |
|
Arimura |
Feb 09, 2024 |
|
|
199804 |
E3_pENTR_L3-L2_NN_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199803 |
E3_pENTR_L3-L2_NI_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199802 |
E3_pENTR_L3-L2_NG_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199801 |
E3_pENTR_L3-L2_HD_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199800 |
E1_pENTR_L1-L4_NN_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199799 |
E1_pENTR_L1-L4_NI_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199798 |
E1_pENTR_L1-L4_NG_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199797 |
E1_pENTR_L1-L4_HD_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191614 |
E3_pENTR_L3-L2_NN_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191613 |
E3_pENTR_L3-L2_NI_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191612 |
E3_pENTR_L3-L2_NG_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191611 |
E3_pENTR_L3-L2_HD_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191610 |
E3_pENTR_L3-L2_NN_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191609 |
E3_pENTR_L3-L2_NI_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191608 |
E3_pENTR_L3-L2_NG_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191607 |
E3_pENTR_L3-L2_HD_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191606 |
E1_pENTR_L1-L4_NN_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191605 |
E1_pENTR_L1-L4_NI_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191604 |
E1_pENTR_L1-L4_NG_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191603 |
E1_pENTR_L1-L4_HD_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11′), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191602 |
E1_pENTR_L1-L4_NN_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191601 |
E1_pENTR_L1-L4_NI_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191600 |
E1_pENTR_L1-L4_NG_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191599 |
E1_pENTR_L1-L4_HD_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191598 |
E3_pENTR_L3-L2_NN_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191597 |
E3_pENTR_L3-L2_NI_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191596 |
E3_pENTR_L3-L2_HD_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191595 |
E3_pENTR_L3-L2_NN_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191594 |
E3_pENTR_L3-L2_NI_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191593 |
E3_pENTR_L3-L2_HD_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191592 |
E3_pENTR_L3-L2_NN_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191591 |
E3_pENTR_L3-L2_NI_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191590 |
E3_pENTR_L3-L2_HD_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191589 |
E3_pENTR_L3-L2_NN_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191588 |
E3_pENTR_L3-L2_NI_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191587 |
E3_pENTR_L3-L2_HD_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
